| 摘要 |
<p>This patent describes a procedure related to the pasteurization of blood plasma product selected of the group containing plasma solution used for therapeutic purposes in order to compensate shortage related to blood coagulability factors V, XI and XIII, total plasma for therapeutic purposes and supernatant cryoprecipitated plasma, where cryoproteins are removed, while this procedure is based on that principle that, the plasma product is supplied by additives containing sorbitol 500 up to 800 g, heparine 100 up to 1000 units, calcium chloride 3 up to 5 mmol, lysine 1 up to 10 g, where all of these amounts are related to one litre of plasma product to be processed. The created mixture is undertaken to heat treating and the supplied additives are being removed with the use of dialyse. The facility enabling to provide this procedure is created based on the mixture containing sorbitol, heparin, calcium chloride and lysine in a ratio of 500 up to 800 g : 100 up to 1000 units : 3 up to 5 mmol : 1 up to 10 g. This solution enables the heat treating of large volumes related to blood plasma, it means up to several hundred liters.</p> |
